Studies on risk of leprosy relapses in China: Relapses after treatment with dapsone monotherapy

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 67, Issue 4, 1999, Pages 371-378

  Chen, Xiang Sheng ^a   Li, Wen Zhong ^a   Jiang, Cheng ^a   Ye, Gan Yun ^a  

^a National Center for STD Control   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE;

ARTICLE; CHINA; FOLLOW UP; HUMAN; INFECTION RISK; LEPROSY; MAJOR CLINICAL STUDY; RELAPSE; RISK ASSESSMENT;

CHINA; DAPSONE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0033368086     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. ALMEIDA, J. G., CHRISTIAN, M. and CHACKO, C. J. Follow up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India. Int. J. Lepr. 51 (1983) 382-384.
2. BECX-BLEUMINK, M. Relapse in leprosy patients after release from treatment from dapsone monotherapy: experiences in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int. J. Lepr. 60 (1992) 161-172.
3. CARTEL, J.-L., BOUTIN, J.-P., SPIEGAL., A., PLICHART, R. and ROUX, J.-F. Longitudinal study on relapses of leprosy in Polynesian multibacillary patients on dapsone monotherapy between 1946 and 1970. Lepr. Rev. 62 (1991) 186-192.
4. EDITORIAL GROUP. Practical Leprosy. Nanjing: Jiangsu People's Publishing House, 1976, pp. 333-335.
5. JESUDASAN, K., CHRISTIAN, M. and BRADLEY, D. Relapse rates among nonlepromatous patients released from control. Int. J. Lepr. 52 (1984) 304-310.
6. KURZ, X. M., DECLERQ, E. E. and VELLUT, C. M. Rate and time distribution of relapses in multibacillary leprosy. Int. J. Lepr. 57 (1989) 599-606.
7. LI, H. Y. Problems of leprosy relapse in China. Int. J. Lepr. 61 (1993) 1-7.
8. MA, H. D. Handbook of Leprosy Control. Nanjing: Jiangsu Science and Technology Press, 1989, pp. 269-270.
9. PANDIAN, T. D., MULIYIL, J. and VELLUT, C. Risk of relapse among nonlepromatous patients released from treatment after dapsone monotherapy. Lepr. Rev. 61 (1991) 288-296.
10. PEAT, M., BROLIN, L., GANAPATI, R., MCDOUGALL, A. C., REVANKAR, C. R. and WATSON, J. W. An evaluation of the contribution of the Swedish International Development Authority (SIDA) to leprosy control in India based on the implementation of multiple drug therapy (MDT) 1981-1993. Indian J. Lepr. 67 (1995) 447-465.
11. SMITH, T. C. and RICHARDUS, J. H. Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era. Int. J. Lepr. 62 (1994) 353-358.
12. WORLD HEALTH ORGANIZATION. Chemotherapy of leprosy. Geneva: World Health Organization, 1994. Tech. Rep. Ser. 847.